StockVS

NASDAQ · USD

Liminatus Pharma, Inc. (LIMNW) Stock Analysis

Liminatus Pharma, Inc. (LIMNW) is a stock listed on NASDAQ and quoted in US Dollar.

LIMNW

$0.06

+$0.01 (+26.90%)

Aug 31, 2026 · Market close

This is a derivative instrument — a warrant on Liminatus Pharma, Inc. (LIMN) common stock.

Issuer fundamentals are shown on the issuer page, not here.

View LIMN →

Price History

Hover for the daily close. The dotted line marks the period open.

LIMNW Key Statistics

As of Aug 31, 2026
Trading
Open
$0.07
Previous Close
$0.04
Volume
2.05K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.71

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

LIMNW Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−22.47%
2025 (partial year)+0.00%

As of August 31, 2026.

Recent News

News provided by third-party sources. Not financial advice.

About Liminatus Pharma, Inc.

Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company was founded in 2018 and is based in Cerritos, California.

Visit website →